ono 1078 has been researched along with Carcinoma, Mucoepidermoid in 1 studies
pranlukast: SRS-A antagonist; leukotriene D4 receptor antagonist
Carcinoma, Mucoepidermoid: A tumor of both low- and high-grade malignancy. The low-grade grow slowly, appear in any age group, and are readily cured by excision. The high-grade behave aggressively, widely infiltrate the salivary gland and produce lymph node and distant metastases. Mucoepidermoid carcinomas account for about 21% of the malignant tumors of the parotid gland and 10% of the sublingual gland. They are the most common malignant tumor of the parotid. (From DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p575; Holland et al., Cancer Medicine, 3d ed, p1240)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bai, CH | 1 |
| Song, SY | 1 |
| Kim, YD | 1 |
1 other study available for ono 1078 and Carcinoma, Mucoepidermoid
| Article | Year |
|---|---|
The inhibitory effect of the leukotriene receptor antagonist on leukotriene D4-induced MUC2/5AC gene expression and mucin secretion in human airway epithelial cells.
Topics: Carcinoma, Mucoepidermoid; Cell Line, Tumor; Chromones; Down-Regulation; Gene Expression; Humans; Le | 2007 |